Related Experiment Video
Updated: Aug 17, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
[Epidemiology and natural history of hepatitis C]
Jean-Pierre Bronowicki1, Hélène Barraud, Laurent Peyrin-Biroulet
1Service d'hépato-gastroentérologie, CHU de Nancy et Inserm EMI 14, 54500 Vandoeuvre-les-Nancy. jp.bronowicki@chu-nancy.fr
Abstract:
The estimated prevalence of hepatitis C infection in France is of 0.86%. The use of intravenous drugs is currently the main cause of hepatitis C infection and it may be responsible for 4400 new infections per year in France. The acute HCV infection is commonly asymptomatic and the progression from acute to chronic hepatitis range from 55 to 85%. Age at infection, alcohol consumption and gender have a significant impact on the progression of fibrosis. The fibrosis seems to progress linearly with an acceleration after 50 years of age. HCV is the second cause of cirrhosis and hepatocellular carcinoma in France.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease
Causality in Epidemiology

